Literature DB >> 27537

Plasma levels of clobazam after three oral dosage forms in health subjects.

J J Vallner, T E Needham, H W Jun, W J Brown, J T Stewart, J A Kotzan, I L Honigberg.   

Abstract

As can be seen from the tables, the terminal half-life of clobazam is about 50 hours, and from a solid dosage form the peak plasma level occurs approximately 1.5 hours after ingestion. Thus, there is a significant, yet relatively short, dosage form delay effect when the solid dosage forms are compared to the rapidly available solution of the drug. However, based on the areas under the curve, comparison of the solid dosage forms with the solution indicates that the fraction of clobazam absorbed is 1. Pupil diameter measurement at 2, 4, and 6 hours after ingestion of clobazam correlated well with the plasma levels at these times. Pupils were constricted to the highest degree at 2 hours and approached the initial pupillary diameter at the 6-hour measurement.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 27537     DOI: 10.1002/j.1552-4604.1978.tb01600.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  4 in total

Review 1.  Clinical pharmacokinetics of non-opiate abused drugs.

Authors:  U Busto; R Bendayan; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

2.  Clobazam plasma concentrations: pharmacokinetic study in healthy volunteers and data in epileptic patients.

Authors:  G Tedeschi; R Riva; A Baruzzi
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

3.  A physiologically based pharmacokinetic model for clobazam and stiripentol in adults and children.

Authors:  Kayode Ogungbenro; Leon Aarons
Journal:  Pharm Res       Date:  2014-07-23       Impact factor: 4.200

Review 4.  A Comprehensive Overview of the Clinical Pharmacokinetics of Clobazam.

Authors:  Dwain Tolbert; Frank Larsen
Journal:  J Clin Pharmacol       Date:  2018-10-04       Impact factor: 3.126

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.